Chi_Principles and Practice of Gynecologic Oncology 8e

Chapter 2.6 ■ Therapy for Vulvar Cancer: Radiation, Systemic Therapy, and Treatment of Persistent and Recurrent Disease 27

15. Hyde SE, Valmadre S, Hacker NF, et al. Squamous cell carcinoma of the vulva with bulky positive groin nodes-nodal debulking versus full groin dis section prior to radiation therapy. Int J Gynecol Cancer . 2007;17(1):154-158. 16. Thaker NG, Klopp AH, Jhingran A, et al. Survival outcomes for pa tients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system? Gynecol Oncol . 2015;136(2):269-273. 17. Piura B, Masotina A, Murdoch J, et al. Recurrent squamous cell carci noma of the vulva: a study of 73 cases. Gynecol Oncol . 1993;48(2):189-195. 18. Woelber L, Eulenburg C, Kosse J, et al. Predicting the course of disease in recurrent vulvar cancer—a subset analysis of the AGO-CaRE-1 study. Gynecol Oncol . 2019;154(3):571-576. 19. Phillips GL, Bundy BN, Okagaki T, et al. Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gyne cologic Oncology Group. Cancer . 1994;73(10):2626-2632. 20. Wechter ME, Reynolds RK, Haefner HK, et al. Vulvar melanoma: review of diagnosis, staging, and therapy. J Low Genit Tract Dis . 2004;8(1):58-69. 21. Moxley KM, Fader AN, Rose PG, et al. Malignant melanoma of the vulva: an extension of cutaneous melanoma? Gynecol Oncol . 2011;122(3):612-617. 22. Sugiyama VE, Chan JK, Shin JY, et al. Vulvar melanoma: a multivari able analysis of 644 patients. Obstet Gynecol . 2007;110(2 pt 1):296-301. 23. Janco JM, Markovic SN, Weaver AL, et al. Vulvar and vaginal mel anoma: case series and review of current management options including neoadjuvant chemotherapy. Gynecol Oncol . 2013;129(3):533-537. 24. Lui PC, Fan YS, Lau PP, et al. Vulvar basal cell carcinoma in China: a 13-year review. Am J Obstet Gynecol . 2009;200(5):514.e1-514.e5. 25. Fuh KC, Berek JS. Current management of vulvar cancer. Hematol On col Clin North Am . 2012;26(1):45-62. 26. Creasman WT, Gallager HS, Rutledge F. Paget’s disease of the vulva. Gynecol Oncol . 1975;3(2):133-148. 27. Fanning J, Lambert HC, Hale TM, et al. Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol . 1999;180(1 pt 1):24-27. 28. Ciavattini A, Sopracordevole F, Di Giuseppe J. Surgical treatment of Paget disease of the vulva: prognostic significance of stromal invasion and surgical margin status. J Low Genit Tract Dis . 2016;20(3):e53-e54. 29. Niikura H, Yoshida H, Ito K, et al. Paget’s disease of the vulva: clinico pathologic study of type 1 cases treated at a single institution. Int J Gynecol Cancer . 2006;16(3):1212-1215. 30. Black D, Tornos C, Soslow RA, et al. The outcomes of patients with positive margins after excision for intraepithelial Paget’s disease of the vulva. Gynecol Oncol . 2007;104(3):547-550. 31. Ho SA, Aw DC. Extramammary Paget’s disease treated with topical imiquimod 5% cream. Dermatol Ther . 2010;23(4):423-427. 32. Feldmeyer L, Kerl K, Kamarashev J, et al. Treatment of vulvar Paget disease with topical imiquimod: a case report and review of the literature. J Dermatol Case Rep . 2011;5(3):42-46. 33. Edey KA, Allan E, Murdoch JB, Cooper S, Byant A. Interventions for the treatment of Paget’s disease of the vulva. Cochrane Database Syst Rev . 2019;6(6):CD009245. 34. Son S, Lee J, Kim Y, et al. The role of radiation therapy for the extrama mmary Paget’s disease of the vulva; experience of 3 cases. Cancer Res Treat . 2005;37(6):365-369. 35. Helgason NM, Hass AC, Latourette HB. Radiation therapy in carci noma of the vulva: a review of 53 patients. Cancer . 1972;30(4):997-1000. 36. Busch M, Wagener B, Duhmke E. Long-term results of radiotherapy alone for carcinoma of the vulva. Adv Ther . 1999;16(2):89-100. 37. Chan JK, Sugiyama V, Pham H, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol . 2007;104:636-641. 38. Heaps JM, Fu YS, Montz FJ, et al. Surgical-pathologic variables predic tive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol . 1990;38(3):309-314. 40. Faul CM, Mirmow D, Huang Q, et al. Adjuvant radiation for vul var carcinoma: improved local control. Int J Radiat Oncol Biol Phys . 1997;38(2):381-389. 41. Viswanathan AN, Pinto AP, Schultz D, et al. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol . 2013;130(3):545-549. 42. Chapman BV, Gill BS, Viswanathan AN, et al. Adjuvant radiation ther apy for margin-positive vulvar squamous cell carcinoma: defining the ideal dose-response using the National Cancer Data Base. Int J Radiat Oncol Biol Phys . 2017;97:107-117.

43. Woelber L, Prieske K, Eulenburg CZ, et al. Adjuvant radiotherapy and local recurrence in vulvar cancer—a subset analysis of the AGO-CaRE-1 study. Gynecol Oncol . 2022;164(1):68-75. 44. Ashmore S, Crafton SM, Miller EM, et al. Optimal overall treatment time for adjuvant therapy for women with completely resected, node-­ positive vulvar cancer. Gynecol Oncol . 2021;161:63-69. 45. Gonzalez Bosquet J, Kinney WK, Russell AH, et al. Risk of occult inguinofemoral lymph node metastasis from squamous carcinoma of the vulva. Int J Radiat Oncol Biol Phys . 2003;57:419-424. 46. Stehman FB, Bundy BN, Thomas G, et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys . 1992;24(2):389-396. 47. McCall AR, Olson MC, Potkul RK. The variation of inguinal lymph node depth in adult women and its importance in planning elective irradi ation for vulvar cancer. Cancer . 1995;75(9):2286-2288. doi:10.1002/1097 0142(19950501)75:9 < 2286::AID-CNCR2820750916 > 3.0.CO;2-G 48. Koh WJ, Chiu M, Stelzer KJ, et al. Femoral vessel depth and the implications for groin node radiation. Int J Radiat Oncol Biol Phys . 1993;27(4):969-974. 49. Katz A, Eifel PJ, Jhingran A, et al. The role of radiation therapy in pre venting regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys . 2003;57(2):409-418. 50. Leiserowitz GS, Russell AH, Kinney WK, et al. Prophylactic chemo radiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol . 1997;66(3):509-514. 51. Beriwal S, Shukla G, Shinde A, et al. Preoperative intensity mod ulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse. Int J Radiat Oncol Biol Phys . 2013;85(5):1269-1274. 52. Beriwal S, Coon D, Heron DE, et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gy necol Oncol . 2008;109(2):291-295. 53. Homesley HD, Bundy BN, Sedlis A, et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol . 1986;68(6):733-740. 54. Parthasarathy A, Cheung MK, Osann K, et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol . 2006;103(3):1095-1099. 55. Mahner S, Jueckstock J, Hilpert F, et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst . 2015;107(3):dju426. 56. Xanthopoulos E, Mitra N, Grover S, et al. Adjuvant radiation therapy in node-positive vulvar cancer. Int J Radiat Oncol Biol Phys . 2013;87(2): S128-S129. 57. Gill BS, Bernard ME, Lin JF, et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol . 2015;137:365-372. 58. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenec tomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol . 2013;128(2):155-159. 59. Glaser S, Olawaiye A, Huang M, et al. Inguinal nodal region radio therapy for vulvar cancer: are we missing the target again? Gynecol Oncol . 2014;135(3):583-585. 60. Hacker NF, Berek JS, Juillard GJ, et al. Preoperative radiation therapy for locally advanced vulvar cancer. Cancer . 1984;54(10):2056-2061. 61. Jafari K, Magalotti F, Magalotti M. Radiation therapy in carcinoma of the vulva. Cancer . 1981;47(4):686-691. 62. Moore DH, Thomas GM, Montana GS, et al. Preoperative chemora diation for advanced vulvar cancer—a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys . 1998;42(1):79-85. 63. Mak RH, Halasz LM, Tanaka CK, et al. Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every- 3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva. Gynecol Oncol . 2011;120(1):101-107. 65. Stecklein SR, Frumovitz M, Klopp AH, et al. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol . 2018;148:474-479. 66. Richman AH, Vargo JA, Ling DC, et al. Dose-escalated intensity mod ulated radiation therapy in patients with locally-advanced vulvar cancer— does it increase response rate? Gynecol Oncol . 2020;159:657-662. 67. van Triest B, Rasing M, van der Velden J, et al. Phase II study of defini tive chemoradiation for locally advanced squamous cell cancer of the vulva: an efficacy study. Gynecol Oncol . 2021;163:117-124.

Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited. 39. Ignatov T, Eggemann H, Burger E, et al. Adjuvant radiotherapy for vul var cancer with close or positive surgical margins. J Cancer Res Clin Oncol . 2016;142:489-495. 64. Montana GS, Thomas GM, Moore DH, et al. Preoperative chemo-­ radiation for carcinoma of the vulva with N2/N3 nodes: a Gyneco logic Oncology Group study. Int J Radiat Oncol Biol Phys . 2000;48(4): 1007-1013.